H
Hiroyuki Daiko
Publications - 183
Citations - 2909
Hiroyuki Daiko is an academic researcher. The author has contributed to research in topics: Esophagectomy & Medicine. The author has an hindex of 25, co-authored 141 publications receiving 2128 citations.
Papers
More filters
Journal ArticleDOI
Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).
Kenichi Nakamura,Ken Kato,Hiroyasu Igaki,Yoshinori Ito,Junki Mizusawa,Nobutoshi Ando,Harushi Udagawa,Yasuhiro Tsubosa,Hiroyuki Daiko,Shuichi Hironaka,Haruhiko Fukuda,Yuko Kitagawa +11 more
TL;DR: The purpose of this study is to confirm the superiority of docetaxel, cisplatin plus 5-fluorouracil with chemoradiotherapy over cisPlatin plus5-fluorbacil as preoperative therapy for squamous cell carcinoma of esophagus.
Journal ArticleDOI
Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma
Hiroki Hara,Makoto Tahara,Hiroyuki Daiko,Ken Kato,Hiroyasu Igaki,Shigenori Kadowaki,Yoichi Tanaka,Yasuo Hamamoto,Hisayuki Matsushita,Michitaka Nagase,Yoshinori Hosoya +10 more
TL;DR: Preliminary data from a multicenter phase II feasibility study of preoperative chemotherapy with DCF for ESCC suggest that preoperative DCF was well tolerated and antitumor activity was highly promising and warrants further investigation.
Journal ArticleDOI
Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
Yukinori Kurokawa,Hiroya Takeuchi,Yuichiro Doki,Shinji Mine,Masanori Terashima,Takushi Yasuda,Kazuhiro Yoshida,Hiroyuki Daiko,Shinichi Sakuramoto,Takaki Yoshikawa,Chikara Kunisaki,Yasuyuki Seto,Shigeyuki Tamura,Toshio Shimokawa,Takeshi Sano,Yuko Kitagawa +15 more
TL;DR: The study accurately identified the distribution of lymph node metastases from EGJ tumors and the optimal extent of subsequent lymph node dissection.
Journal ArticleDOI
Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y,Taira Kinoshita,Masaru Konishi,Shinichiro Takahashi,Naoto Gotohda,Kato Y,Hiroyuki Daiko,Mitsuyo Nishimura,Katsumata K,Yasuyuki Sugiyama +9 more
TL;DR: Mediastinal lymph node metastasis and tumor depth were significant and independent factors for poor prognosis after R0 resection for AEG, and esophageal invasion and histopathological grade weresignificant and independent factor for mediastinalymph nodes metastasis.
Journal ArticleDOI
Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection.
Hiroyasu Igaki,Hoichi Kato,Yuji Tachimori,Hiroyuki Daiko,Masahide Fukaya,Satoshi Yajima,Yukihiro Nakanishi +6 more
TL;DR: Three-field lymph node dissection may be indicated even for patients with clinical Stage I squamous cell carcinoma requiring surgical intervention because this surgical procedure provides for possible cure by removing unsuspected lymph node metastasis.